Gene · 6300
Papers1,954
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,954
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A hybrid approach unveils drug repurposing candidates targeting an Alzheimer pathophysiology mechanism. | Patterns (N Y) | 2022 | 35510183 | PubTator, text mining | PubMed |
| Role of p38 MAP kinase in cancer stem cells and metastasis. | Oncogene | 2022 | 35501462 | PubTator, text mining | PubMed |
| FGFR1 is a potential therapeutic target in neuroblastoma. | Cancer Cell Int | 2022 | 35488346 | PubTator, text mining | PubMed |
| Proteomics of lung tissue reveals differences in inflammation and alveolar-capillary barrier response between atelectasis and aerated regions. | Sci Rep | 2022 | 35487970 | PubTator, text mining | PubMed |
| Reptiles as Promising Sources of Medicinal Natural Products for Cancer Therapeutic Drugs. | Pharmaceutics | 2022 | 35456708 | PubTator, text mining | PubMed |
| Natural Phaeosphaeride A Derivatives Overcome Drug Resistance of Tumor Cells and Modulate Signaling Pathways. | Pharmaceuticals (Basel) | 2022 | 35455394 | PubTator, text mining | PubMed |
| Structural and Enzymological Evidence for an Altered Substrate Specificity in Okur-Chung Neurodevelopmental Syndrome Mutant CK2αLys198Arg. | Front Mol Biosci | 2022 | 35445078 | PubTator, text mining | PubMed |
| Impact of APOE genotype on prion-type propagation of tauopathy. | Acta Neuropathol Commun | 2022 | 35440098 | PubTator, text mining | PubMed |
| De novo identification of maximally deregulated subnetworks based on multi-omics data with DeRegNet. | BMC Bioinformatics | 2022 | 35439941 | PubTator, text mining | PubMed |
| Metastasis and MAPK Pathways. | Int J Mol Sci | 2022 | 35409206 | PubTator, text mining | PubMed |
| Overcoming Steroid Resistance in Pediatric Acute Lymphoblastic Leukemia-The State-of-the-Art Knowledge and Future Prospects. | Int J Mol Sci | 2022 | 35409154 | PubTator, text mining | PubMed |
| Involvement of Cancer Stem Cells in Chemoresistant Relapse of Epithelial Ovarian Cancer Identified by Transcriptome Analysis. | J Oncol | 2022 | 35401749 | PubTator, text mining | PubMed |
| A Comprehensive Review on the Therapeutic Potential of Curcuma longa Linn. in Relation to its Major Active Constituent Curcumin. | Front Pharmacol | 2022 | 35401176 | PubTator, text mining | PubMed |
| CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis. | Clin Transl Med | 2022 | 35384345 | PubTator, text mining | PubMed |
| Predicted coronavirus Nsp5 protease cleavage sites in the human proteome. | BMC Genom Data | 2022 | 35379171 | PubTator, text mining | PubMed |
| Phosphorylation-Dependent Regulation of WNT/Beta-Catenin Signaling. | Front Oncol | 2022 | 35359365 | PubTator, text mining | PubMed |
| Effect of the p38 Mitogen-Activated Protein Kinase Signaling Cascade on Radiation Biodosimetry. | Radiat Res | 2022 | 35353886 | PubTator, text mining | PubMed |
| Infection of Human Endothelial Cells with Lassa Virus Induces Early but Transient Activation and Low Type I IFN Response Compared to the Closely-Related Nonpathogenic Mopeia Virus. | Viruses | 2022 | 35337059 | PubTator, text mining | PubMed |
| Potential Anti-Inflammatory Effects of a New Lyophilized Formulation of the Conditioned Medium Derived from Periodontal Ligament Stem Cells. | Biomedicines | 2022 | 35327485 | PubTator, text mining | PubMed |
| Comprehensive Analysis of TRP Channel-Related Genes for Estimating the Immune Microenvironment, Prognosis, and Therapeutic Effect in Patients With Esophageal Squamous Cell Carcinoma. | Front Cell Dev Biol | 2022 | 35309940 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6300/papers?page=19